Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ethyl salicylate is a small molecule analgesic and anti-inflammatory agent belonging to the salicylate class. It is the ethyl ester of salicylic acid and is primarily used topically for the relief of musculoskeletal pain and inflammation, including sports-related pain. Its mechanism of action involves inhibition of cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) enzymes, leading to reduced prostaglandin synthesis and thus decreased pain and inflammation. Additionally, it acts as a counter-irritant by promoting local vasodilation when applied to the skin. Ethyl salicylate is also used in perfumery and artificial flavors due to its pleasant wintergreen-like odor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ethyl salicylate.